SectorPharmaceutical
Established Date08/02/2016
Listing Date30/07/2021
ExchangeNASDAQ Stock Exchange
Full-time Employees17
Fiscal Year Ends31/12
Security TypeCommon stock
Office address350 5th Avenue, Suite 5330 , New York, New York 10118
Business
IntroductionIn8 bio, Inc., was incorporated in Bermuda on February 8, 2016. The Company is a leading clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cell therapy candidates and gamma-delta T cell ligators for cancer and autoimmune diseases.
